NORTHWEST BIOTHERAPEUTICS INC Business Finance Contracts & Agreements
83 Contracts & Agreements
- Escrow Agreements (1 contract)
- Exchange Agreements (2)
- Indenture Agreements (3)
- Loan Agreements (22)
- Note Agreements (3)
- Purchase Agreements (7)
- Registration Rights Agreements (1)
- Security Agreements (1)
- Stock Agreements (14)
- Subscription Agreements (2)
- Underwriting Agreements (3)
- Warrant Agreements (24)
- Loan Agreement, dated November 10, 2023, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 5, 2024)
- Loan Agreement, dated March 2, 2023, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 5, 2024)
- Loan Agreement, dated September 26, 2022, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on February 28, 2023)
- Loan Agreement, dated November 22, 2021, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 1, 2022)
- Loan Agreement, dated March 1, 2021, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 31, 2021)
- Note and Loan Agreement, dated August 14, 2021, by and between Northwest Biotherapeutics, Inc. and Iliad Research and Trading L.P (Filed With SEC on March 31, 2021)
- Form of Loan Agreement, dated as of November 7, 2018, by and between Northwest Biotherapeutics, Inc. and a Group of Private Lenders (Filed With SEC on April 2, 2019)
- Promissory Note in the principal amount of $1,388,888.89, dated as of May 1, 2018, by and between Northwest Biotherapeutics, Inc. and Adar Bays, LLC (Filed With SEC on April 2, 2019)
- Note and Loan Agreement, dated as of March 19, 2018, by and between Northwest Biotherapeutics, Inc. and Linda F. Powers (Filed With SEC on April 2, 2019)
- Note and Loan Agreement, dated as of March 14, 2018, by and between Northwest Biotherapeutics, Inc. and Linda F. Powers (Filed With SEC on April 2, 2019)
- Form of Class D-3 Common Stock Purchase Warrant (Filed With SEC on June 28, 2018)
- Form of Securities Purchase Agreement, dated June 22, 2017, by and between Northwest Biotherapeutics, Inc. and certain purchasers (Filed With SEC on June 28, 2018)
- Form of Subscription Agreement (Filed With SEC on January 4, 2018)
- Form of Class D-2 Common Stock Purchase Warrant (Filed With SEC on January 4, 2018)
- Form of Subscription Agreement (Filed With SEC on December 7, 2017)
- Form of Class D-1 Common Stock Purchase Warrant (Filed With SEC on December 7, 2017)
- Form of Class A Common Stock Purchase Warrant (Filed With SEC on September 22, 2017)
- Form of Securities Purchase Agreement, dated September 20, 2017, by and between Northwest Biotherapeutics, Inc. and certain institutional investors (Filed With SEC on September 22, 2017)
- NORTHWEST BIOTHERAPEUTICS,INC. LOAN AGREEMENT and PROMISSORY NOTE (Filed With SEC on August 21, 2017)
- COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on August 7, 2017)
- NORTHWEST BIOTHERAPEUTICS,INC. SECOND SUPPLEMENTAL INDENTURE (Filed With SEC on June 13, 2017)
- 430 Park Avenue | New York, New York 10022 | 212 ###-###-#### Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC (Filed With SEC on March 23, 2017)
- CLASS C COMMON STOCK PURCHASE WARRANT NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on March 23, 2017)
- CLASS B COMMON STOCK PURCHASE WARRANT NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on March 23, 2017)
- CLASS A COMMON STOCK PURCHASE WARRANT NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on March 23, 2017)
- NORTHWEST BIOTHERAPEUTICS,INC. FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on March 23, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 19, 2016)
- SERIES E COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on September 19, 2016)
- EXCHANGE AGREEMENT (Filed With SEC on September 6, 2016)
- COMMON STOCK PURCHASE WARRANT NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on July 11, 2016)
- SERIES [A/B/C] COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on March 3, 2016)
- COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on December 29, 2015)
- NORTHWEST BIOTHERAPEUTICS,INC. STOCK PURCHASE AGREEMENT (Filed With SEC on April 8, 2015)
- STOCK PURCHASE, AMENDMENT AND ISSUANCEAGREEMENT (Filed With SEC on October 10, 2014)
- COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on October 10, 2014)
- PLEDGE AND ESCROW AGREEMENT (Filed With SEC on August 25, 2014)
- NORTHWEST BIOTHERAPEUTICS, INC., and TheBank of New York Mellon, as Trustee INDENTURE Dated as of August 19, 2014 5.00% Convertible Senior Notes due 2017 (Filed With SEC on August 25, 2014)
- NORTHWEST BIOTHERAPEUTICS, INC. 5.00% Convertible Senior Notes due 2017 Purchase Agreement (Filed With SEC on August 19, 2014)
- COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on April 14, 2014)
- COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on November 20, 2013)
